COR Q3 2019 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q3 2019 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$45.2B+4.9% YoY

Gross Profit

$1.1B2.5% margin

Operating Income

$463M1.0% margin

Net Income

$302M0.7% margin

EPS (Diluted)

$1.43

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

$568M

Free Cash Flow

$499M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$38.5B

Total Liabilities

$35.4B

Stockholders' Equity

$3.0B

Cash & Equivalents

$3.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45.2B	$43.1B	+4.9%
Gross Profit	$1.1B	$1.1B	+6.1%
Operating Income	$463M	$429M	+7.9%
Net Income	$302M	$276M	+9.5%

Revenue Segments

Pharmaceutical Distribution

$43.5B96%

Other Segments

$1.7B4%

Geographic Segments

Other Segments

$1.7B100%